HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Relation of activation-induced deaminase (AID) expression with antibody response to A(H1N1)pdm09 vaccination in HIV-1 infected patients.

Abstract
The relevance of CD4+T-cells, viral load and age in the immunological response to influenza infection and vaccination in HIV-1 infected individuals has previously been pointed out. Our study aimed at assessing, in the setting of 2009 A(H1N1)pdm09 influenza vaccination, whether quantification of activation-induced deaminase (AID) expression in blood B-cells may provide additional indications for predicting antibody response to vaccination in HIV-1 infected patients with similar CD4+T-cell counts and age. Forty-seven healthy controls, 37 ART-treated and 17 treatment-naïve HIV-1 infected patients were enrolled in the study. Blood was collected prior to A(H1N1)pdm09 vaccination and at 1, 3 and 6 months after vaccination. Antibody titers to A(H1N1)pdm09 vaccine were measured by hemagglutination inhibition (HI) assay while the mRNA expression levels of AID were measured by quantitative real time PCR. Upon B-cell activation in vitro, AID increase correlated to antibody response to the A(H1N1)pdm09 vaccine at 1 month after vaccination in all individuals. In addition, the maximum expression levels of AID were significantly higher in those individuals who still carried protective levels of A(H1N1)pdm09 antibodies after 6 months from vaccination. No correlation was found between CD4+T-cell counts or age at vaccination or HIV-1 viral load and levels of A(H1N1)pdm09 antibodies. Assessing AID expression before vaccination may be an additional useful tool for defining a vaccination strategy in immune-compromised individuals at risk of immunization failure.
AuthorsAlberto Cagigi, Simone Pensieroso, Nicolas Ruffin, Stefano Sammicheli, Rigmor Thorstensson, Qiang Pan-Hammarström, Bo Hejdeman, Anna Nilsson, Francesca Chiodi
JournalVaccine (Vaccine) Vol. 31 Issue 18 Pg. 2231-7 (Apr 26 2013) ISSN: 1873-2518 [Electronic] Netherlands
PMID23499520 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
CopyrightCopyright © 2013 Elsevier Ltd. All rights reserved.
Chemical References
  • Antibodies, Viral
  • Influenza Vaccines
  • AICDA (activation-induced cytidine deaminase)
  • Cytidine Deaminase
Topics
  • Adult
  • Antibodies, Viral (blood, immunology)
  • Antibody Formation (immunology)
  • B-Lymphocytes (immunology, virology)
  • CD4 Lymphocyte Count
  • Cytidine Deaminase (immunology)
  • Female
  • HIV Infections (immunology, virology)
  • HIV-1
  • Healthy Volunteers
  • Hemagglutination Inhibition Tests
  • Humans
  • Influenza A Virus, H1N1 Subtype (immunology)
  • Influenza Vaccines (administration & dosage, immunology)
  • Influenza, Human (immunology, prevention & control, virology)
  • Lymphocyte Activation (immunology)
  • Male
  • Middle Aged
  • Vaccination
  • Viral Load

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: